^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Breakthrough Genomics

    i
    Related tests:
    Evidence
    News
    4ms
    Breakthrough Genomics joins forces with the Precede Consortium to help accelerate the early detection of pancreatic cancer (PRNewswire)
    "Breakthrough Genomics...announced today its collaboration with the PRECEDE Consortium to advance the clinical evaluation and adoption of its BT-Reveal™ Early Pancreatic Cancer Test...The partnership with PRECEDE offers Breakthrough Genomics access to a network of the world's foremost pancreatic cancer researchers, clinicians, and high-risk centers. Led by world-renown surgeon and scientist, Dr. Diane Simeone, the PRECEDE Consortium is conducting the largest longitudinal study of its kind, with over 7,000 patients enrolled across 54 leading institutions."
    Clinical data • Licensing / partnership
    |
    BT-Reveal™ Early Pancreatic Cancer Test